...
首页> 外文期刊>Journal of clinical laboratory analysis. >Correlations between serum amyloid A, C‐reactive protein and clinical indices of patients with acutely exacerbated chronic obstructive pulmonary disease
【24h】

Correlations between serum amyloid A, C‐reactive protein and clinical indices of patients with acutely exacerbated chronic obstructive pulmonary disease

机译:血清淀粉样蛋白A,C反应蛋白和急性加剧慢性阻塞性肺病患者临床指标的相关性

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background To explore the correlations between SAA, CRP, and clinical indices of patients with acutely exacerbated chronic obstructive pulmonary disease (AECOPD). Methods A total of 120 patients with AECOPD and another 120 with remitted COPD were enrolled in an AECOPD group and a COPD remission group, respectively. Meanwhile, 120 healthy subjects were included as a control group. SAA, CRP, PCT, Fbg, IL‐8, IL‐6, TNF‐α, and IP‐10 levels were detected. FEV 1 and FEV 1 /FVC were measured. Results Compared with control group, the serum levels of SAA, CRP, PCT, Fbg, IL‐8, IL‐6, TNF‐α, and IP‐10 significantly increased in COPD remission group ( P ??0.05). The levels of AECOPD group significantly exceeded those of COPD remission group ( P ??0.05). The levels of AECOPD patients with different GOLD grades were significantly different ( P ??0.05). AECOPD group had significantly lower FEV 1 and FEV 1 /FVC than those of COPD remission group ( P ??0.05). The CAT score of AECOPD patients was (18.41?±?2.55) points. The levels of SAA, CRP, PCT, Fbg, IL‐8, IL‐6, TNF‐α, and IP‐10 were negatively correlated with FEV 1 and FEV 1 /FVC, and positively correlated with CAT score. The area under receiver operating characteristic curve of SAA was largest (0.931). The cutoff values for SAA, CRP, PCT and Fbg were 18.68?mg/L, 14.70?mg/L, 0.39?μg/L, 3.91?g/L, 0.46?μg/L, 24.17?μg/L, 7.18?mg/L, and 83.19?ng/L, respectively. Conclusions Serum levels of SAA, CRP, PCT, Fbg, IL‐8, IL‐6, TNF‐α, and IP‐10 in AECOPD patients were elevated, which may undermine pulmonary functions. SAA can be used as an effective index for AECOPD diagnosis and treatment.
机译:背景技术探讨急性加剧慢性阻塞性肺病(AECOPD)患者SAA,CRP和临床指标之间的相关性。方法分别在AECOPD组和副缔约方疾病患者中共有120例患有120名患有艾博多普博和其他120名患者。同时,将120个健康受试者包含作为对照组。检测到SAA,CRP,PCT,FBG,IL-8,IL-6,TNF-α和IP-10水平。测量FEV 1和FEV 1 / FVC。结果与对照组相比,COPD缓解组中SAA,CRP,PCT,FBG,IL-8,IL-6,TNF-α和IP-10的血清水平显着增加(p?& 0.05)。 AECOPD组的水平显着超过了COPD缓解组(P?& 0.05)。 AECOPD患者不同金级的患者的水平显着差异(p≤≤0.05)。 AECOPD组的FEV 1和FEV 1 / FVC显着低于COPD缓解组(P≤≤0.05)。 AECOPD患者的猫分数是(18.41?±2.5​​5)点。 SAA,CRP,PCT,FBG,IL-8,IL-6,TNF-α和IP-10的水平与FEV 1和FEV 1 / FVC负相关,并与CAT分数呈正相关。在Saa的接收器操作特征曲线下的该区域最大(0.931)。 SAA,CRP,PCT和FBG的截止值为18.68Ω·mg / L,14.70×mg / L,0.39≤μg/ L,3.91Ω·μg/ L,24.17?μg/ L,7.18? Mg / L和83.19?Ng / L分别。结论EACOPD患者中SAA,CRP,PCT,FBG,IL-8,IL-6,TNF-α和IP-10的血清水平升高,可能会破坏肺功能。 SAA可作为AECOPD诊断和治疗的有效指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号